Aortech Share Discussion Threads

[brucie5] 24/8/2018 11:28

NY Boy
24 Aug '18 - 11:21 - 1679 of 1680


Plenty of market opportunities being presented ...(SOS), INFA, (EVRH) just a few in play now ..but dyor as usual
--------------------------------------------------------------------------
Maybe add RED to that list..?

[the stigologist] 24/8/2018 11:24

Using the English language may help you in whatever you were hoping to achieve here.

"Landy- thanks,. having seen the the whites of their eyes- was the story believeable, did you palpate the excitement enthusiasm, or underlying anxiety?"

[ny boy] 24/8/2018 11:21

Buyers of dips are back Sir, pays to be patient and reap the excellent prospects going forward.

Plenty of market opportunities being presented ...(SOS), INFA, (EVRH) just a few in play now ..but dyor as usual

[someuwin] 24/8/2018 11:14

I emailed Chairman Bill Brown and asked about the new US patent mentioned in yesterday's AGM update. He replied:

"...Regarding the GELS patent, it is pretty similar to the Brazilian patent but clearly covers a much bigger market"

So that's now a huge market covered by their patent for breast implants.

As we know there is nothing in the current broker 400p target for the breast IP and its only a matter of time before this gets licensed out.

That license alone could be worth more than the current valuation alone. imo.



"04 July 2018

AorTech is pleased to announce that the Brazilian Patent Office has recently granted Patent Number PI 0711694-2 entitled Biostable Gels. The invention relates to biostable gels, the processes for their preparation and their use in the manufacture and repair of biomaterials and medical devices or implants, in particular soft tissue implants such as breast implants.

Bill Brown, Chairman of AorTech said: "The issue of this patent further expands AorTech's patent portfolio, particularly in the area of breast implants. Brazil is one of the largest markets for breast enhancement outside of the USA and is therefore an important patent territory. The portfolio of IP relating to Breast Implants is not currently licensed by AorTech."

[mshilos] 24/8/2018 11:13

SP heading towards £1 before end of Sept according to broker charts and forecast...STRONG BUY...dyor

[donalc] 24/8/2018 11:05

Landy- thanks,. having seen the the whites of their eyes- was the story believeable, did you palpate the excitement enthusiasm, or underlying anxiety?

[turbotrader2] 24/8/2018 11:01

Was it good?

[landy90] 24/8/2018 10:35

donal. yes I was there

[donalc] 24/8/2018 09:37

anyone at yesterday AGM?

[someuwin] 24/8/2018 08:47

At just £10m valuation, this stock is a fantastic opportunity.

[k1ngkonggb] 23/8/2018 18:32

Isn't that a skin affliction on your balls??? :)

90p now, would be great!!!!

[blueball] 23/8/2018 18:14

Ichimoku bull kumo break-out kingnog at 69.5p.

last one at 48p took it to 90p within weeks.

[blueball] 23/8/2018 17:53

Cheers steve.



Buy.

[the stigologist] 23/8/2018 17:43

Quite extraordinary in AIM circles for a stock to go up on an AGM statement

We are in very good hands here as long term shareholders

[steveallen] 23/8/2018 16:29

Well done Blueball looks like you had it right last night. where is the Stig at the moment?

[greedy rooster] 23/8/2018 14:20

Sounds like Stig went to the meeting - no doubt small talk over the coffee and biscuits was enlightening.

[k1ngkonggb] 23/8/2018 12:41

Bones, you're bang on there. Anyway, roll on many multiples from where we are now!

[bones] 23/8/2018 12:38

As they have been so doing for the last five years k1ngkonggb!

[k1ngkonggb] 23/8/2018 12:25

Knowing our luck, the stock market will have crashed by then as some analysts are predicting!

[investordave] 23/8/2018 12:25

Looks very positive Bones and will not be selling a single share for the next 2-3 years at least. And as soon as I have cash available, I'll be buying more. I've yet to come across a share with as much potential as this.

[mshilos] 23/8/2018 12:23

WOW...400p in the next 3 years would be great !!

[bones] 23/8/2018 12:04

Update from Stockdale concludes with:

"....we believe that our 400p target price could prove to be conservative in due course. Given today’s confident AGM statement we are happy to retain our Buy rating."